Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,232 | 16,586 | 19,744 | 31,533 | 24,310 |
| Marketable Securities | 53,151 | 56,332 | 61,598 | 53,535 | 69,712 |
| Receivables | 1,015 | 727 | 1,170 | 2,307 | 3,162 |
| TOTAL | $66,698 | $75,103 | $84,365 | $88,851 | $99,079 |
| Non-Current Assets | |||||
| PPE Net | 4,031 | 4,488 | 5,086 | 5,462 | 6,111 |
| Intangibles | 48,690 | 48,690 | 48,690 | 48,690 | 48,690 |
| Other Non-Current Assets | 3,514 | 3,560 | 4,103 | 4,574 | 1,929 |
| TOTAL | $56,235 | $56,738 | $57,879 | $58,726 | $56,730 |
| Total Assets | $122,933 | $131,841 | $142,244 | $147,577 | $155,809 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 2,550 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,174 | 666 | 1,016 | 1,105 | 1,069 |
| Accrued Expenses | 6,499 | 6,419 | 5,410 | 5,474 | 7,007 |
| Other current liabilities | 2,026 | N/A | 2,545 | 2,777 | 4,526 |
| TOTAL | $11,643 | $11,888 | $11,509 | $11,989 | $12,602 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 17,264 | 18,573 | 21,109 | 22,895 | 19,147 |
| TOTAL | $17,264 | $18,573 | $21,109 | $22,895 | $19,147 |
| Total Liabilities | $28,907 | $30,461 | $32,618 | $34,884 | $31,749 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,575 | 16,130 | 15,019 | 13,769 | 12,440 |
| Common Shares | 17 | 16 | 15 | 13 | 12 |
| Retained earnings | -1,013,316 | -1,002,869 | -991,456 | -979,677 | -962,438 |
| Other shareholders' equity | 2,619 | 2,635 | 2,638 | 2,602 | 2,583 |
| TOTAL | $94,026 | $101,380 | $109,626 | $112,693 | $124,060 |
| Total Liabilities And Equity | $122,933 | $131,841 | $142,244 | $147,577 | $155,809 |